Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion

Study Identifier
MAF/AGN/OPH/RET/009
CT.gov Identifier
NCT01618266
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • dexamethasone intravitreal implant
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Macular oedema due to retinal vein occlusion
    Exclusion Criteria:
    * Not living in metropolitan France

    Protocol Summary

    Epidemiological study of Ozurdex® in sites treating patients with retinal vein occlusion.

    Study Locations

    Location
    Status
    Location
    Paris, France
    Status
    Not applicable